These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14871806)

  • 1. Taxane-mediated antiangiogenesis in vitro: influence of formulation vehicles and binding proteins.
    Ng SS; Figg WD; Sparreboom A
    Cancer Res; 2004 Feb; 64(3):821-4. PubMed ID: 14871806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles.
    Yokogawa K; Jin M; Furui N; Yamazaki M; Yoshihara H; Nomura M; Furukawa H; Ishizaki J; Fushida S; Miwa K; Miyamoto K
    J Pharm Pharmacol; 2004 May; 56(5):629-34. PubMed ID: 15142340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of formulation vehicle on metronomic taxane chemotherapy: albumin-bound versus cremophor EL-based paclitaxel.
    Ng SS; Sparreboom A; Shaked Y; Lee C; Man S; Desai N; Soon-Shiong P; Figg WD; Kerbel RS
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4331-8. PubMed ID: 16857808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere).
    Grant DS; Williams TL; Zahaczewsky M; Dicker AP
    Int J Cancer; 2003 Mar; 104(1):121-9. PubMed ID: 12532428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy.
    Vigano L; Locatelli A; Grasselli G; Gianni L
    Invest New Drugs; 2001 May; 19(2):179-96. PubMed ID: 11392452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel versus paclitaxel for antiangiogenesis.
    Vacca A; Ribatti D; Iurlaro M; Merchionne F; Nico B; Ria R; Dammacco F
    J Hematother Stem Cell Res; 2002 Feb; 11(1):103-18. PubMed ID: 11847007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20.
    Weiszhár Z; Czúcz J; Révész C; Rosivall L; Szebeni J; Rozsnyay Z
    Eur J Pharm Sci; 2012 Mar; 45(4):492-8. PubMed ID: 21963457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactants influence the distribution of taxanes in peritoneal dissemination tumor-bearing rats.
    Kamijo Y; Ito C; Nomura M; Sai Y; Miyamoto K
    Cancer Lett; 2010 Jan; 287(2):182-6. PubMed ID: 19608331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of formulation vehicles in taxane pharmacology.
    van Zuylen L; Verweij J; Sparreboom A
    Invest New Drugs; 2001 May; 19(2):125-41. PubMed ID: 11392447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of polysorbates and Cremophor EL on vascular responses in rat aorta.
    Zengil H; Hodoğlugil U; Güney Z
    Experientia; 1995 Nov; 51(11):1055-9. PubMed ID: 7498444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput combinatorial approach for the discovery of a cremophor EL-free paclitaxel formulation.
    Chen H; Zhang Z; McNulty C; Olbert C; Yoon HJ; Lee JW; Kim SC; Seo MH; Oh HS; Lemmo AV; Ellis SJ; Heimlich K
    Pharm Res; 2003 Aug; 20(8):1302-8. PubMed ID: 12948029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
    Taraboletti G; Micheletti G; Rieppi M; Poli M; Turatto M; Rossi C; Borsotti P; Roccabianca P; Scanziani E; Nicoletti MI; Bombardelli E; Morazzoni P; Riva A; Giavazzi R
    Clin Cancer Res; 2002 Apr; 8(4):1182-8. PubMed ID: 11948131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam.
    Bravo González RC; Huwyler J; Boess F; Walter I; Bittner B
    Biopharm Drug Dispos; 2004 Jan; 25(1):37-49. PubMed ID: 14716751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the development of alternative pharmaceutical formulations of taxanes.
    Nuijen B; Bouma M; Schellens JH; Beijnen JH
    Invest New Drugs; 2001 May; 19(2):143-53. PubMed ID: 11392448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.
    Pan D; Schmieder AH; Wang K; Yang X; Senpan A; Cui G; Killgore K; Kim B; Allen JS; Zhang H; Caruthers SD; Shen B; Wickline SA; Lanza GM
    Theranostics; 2014; 4(6):565-78. PubMed ID: 24723979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
    Malingré MM; Schellens JH; Van Tellingen O; Ouwehand M; Bardelmeijer HA; Rosing H; Koopman FJ; Schot ME; Ten Bokkel Huinink WW; Beijnen JH
    Br J Cancer; 2001 Nov; 85(10):1472-7. PubMed ID: 11720431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteins.
    Loos WJ; Baker SD; Verweij J; Boonstra JG; Sparreboom A
    Clin Pharmacol Ther; 2003 Oct; 74(4):364-71. PubMed ID: 14534523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.
    Sweeney CJ; Miller KD; Sissons SE; Nozaki S; Heilman DK; Shen J; Sledge GW
    Cancer Res; 2001 Apr; 61(8):3369-72. PubMed ID: 11309294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL.
    de Vos AI; Nooter K; Verweij J; Loos WJ; Brouwer E; de Bruijn P; Ruijgrok EJ; van der Burg ME; Stoter G; Sparreboom A
    Ann Oncol; 1997 Nov; 8(11):1145-50. PubMed ID: 9426335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations.
    Tsallas A; Jackson J; Burt H
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):431-44. PubMed ID: 21069339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.